Literature DB >> 10884942

Causes and effects of the chronic inflammation in venous leg ulcers.

M S Agren1, W H Eaglstein, M W Ferguson, K G Harding, K Moore, U K Saarialho-Kere, G S Schultz.   

Abstract

The pathogenesis of venous leg ulcers is multifactorial. In this review article new physiological, molecular and cellular abnormalities in venous ulcers related to the chronic inflammation are presented and discussed. Venous hypertension causes disturbed microcirculation and pathological changes of the capillaries, which eventually locks the condition in a self-amplifying, detrimental cascade with persistent elevated levels and activities of pro-inflammatory cytokines and proteases preventing progress into a healing phase. As a consequence fibroblasts senescence and become less responsive to growth factors the older the ulcers become. Current data imply there is no deficiency but rather an unfavorable distribution of growth factors in venous ulcers. An imbalance in proteolytic enzymes and their endogenous inhibitors is a common finding in chronic venous leg ulcers. Variation in disease severity and concomitant ailments in this heterogeneous patient group may explain the contradictory results in the literature. Thus, to advance the areas of research further, longitudinal studies involving larger number of patients are required to identify the major pathogenic factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884942

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  22 in total

1.  Modelling the interaction of keratinocytes and fibroblasts during normal and abnormal wound healing processes.

Authors:  Shakti N Menon; Jennifer A Flegg; Scott W McCue; Richard C Schugart; Rebecca A Dawson; D L Sean McElwain
Journal:  Proc Biol Sci       Date:  2012-05-23       Impact factor: 5.349

Review 2.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Commercial considerations in tissue engineering.

Authors:  Jonathan Mansbridge
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

4.  Amelogenin is phagocytized and induces changes in integrin configuration, gene expression and proliferation of cultured normal human dermal fibroblasts.

Authors:  Sofia Almqvist; Maria Werthén; Anna Johansson; Magnus S Agren; Peter Thomsen; S Petter Lyngstadaas
Journal:  J Mater Sci Mater Med       Date:  2009-12-10       Impact factor: 3.896

5.  17beta-estradiol inhibits wound healing in male mice via estrogen receptor-alpha.

Authors:  Stephen C Gilliver; Elaine Emmerson; Laura Campbell; Pierre Chambon; Matthew J Hardman; Gillian S Ashcroft
Journal:  Am J Pathol       Date:  2010-05-06       Impact factor: 4.307

6.  Prevalence of obstructive sleep apnea in patients with chronic wounds.

Authors:  Brian T Patt; David Jarjoura; Lynn Lambert; Sashwati Roy; Gayle Gordillo; Richard Schlanger; Chandan K Sen; Rami N Khayat
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

7.  Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Authors:  George R A Cathcart; Derek Quinn; Brett Greer; Pat Harriott; John F Lynas; Brendan F Gilmore; Brian Walker
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

8.  Clinical efficacy of a silver-releasing foam dressing in venous leg ulcer healing: a randomised controlled trial.

Authors:  Patricia Senet; Renzo Bause; Bo Jørgensen; Karsten Fogh
Journal:  Int Wound J       Date:  2013-02-04       Impact factor: 3.315

9.  Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*.

Authors:  Kavitha Subramaniam; Cheryl M Pech; Michael C Stacey; Hilary J Wallace
Journal:  Int Wound J       Date:  2008-03       Impact factor: 3.315

10.  A three species model to simulate application of Hyperbaric Oxygen Therapy to chronic wounds.

Authors:  Jennifer A Flegg; Donald L S McElwain; Helen M Byrne; Ian W Turner
Journal:  PLoS Comput Biol       Date:  2009-07-31       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.